Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit Jan Schuurhuis, Gert J. Ossenkoppele, Marie C. Béné et al.|Blood|2018Cited by 1k
Doxorubicin (adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicityHiskias G. Keizer, Hans Joenje, Herbert M. Pinedo et al.|Pharmacology & Therapeutics|1990Cited by 518